Evidence map›Paper›PMID 24636388›Full record

ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2014

Simultaneous multioutcome synthesis and mapping of treatment effects to a common scale.

Guobing Lu, Daphne Kounali, A E Ades

Open access · hybridAbstract read
In one paragraph

Article in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
11.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  2. Classifying information-sharing methods.BMC medical research methodology · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Guobing LuSchool of Social & Community Medicine, University of Bristol, Bristol, UK.
Daphne KounaliSchool of Social & Community Medicine, University of Bristol, Bristol, UK.
A E AdesSchool of Social & Community Medicine, University of Bristol, Bristol, UK. Electronic address: t.ades@bristol.ac.uk.
University of Bristol · GB

Funding

Medical Research Council G0901488
6 · The paper itself

Abstract

objectivesA new method is presented for both synthesizing treatment effects on multiple outcomes subject to measurement error and estimating coherent mapping coefficients between all outcomes. It can be applied to sets of trials reporting different combinations of patient- or clinician-reported outcomes, including both disease-specific measures and generic health-related quality-of-life measures. It is underpinned by a structural equation model that includes measurement error and latent common treatment effect factor. Treatment effects can be expressed on any of the test instruments that have been used.

methodsThis is illustrated in a synthesis of eight placebo-controlled trials of TNF-α inhibitors in ankylosing spondylitis, each reporting treatment effects on between two and five of a total six test instruments.

resultsThe method has advantages over other methods for synthesis of multiple outcome data, including standardization and multivariate normal synthesis. Unlike standardization, it allows synthesis of treatment effect information from test instruments sensitive to different underlying constructs. It represents a special case of previously proposed multivariate normal models for evidence synthesis, but unlike the former, it also estimates mappings. Combining synthesis and mapping as a single operation makes more efficient use of available data than do current mapping methods and generates treatment effects that are consistent with the mappings. A limitation, however, is that it can only generate mappings to and from those instruments on which some trial data exist.

conclusionsThe method should be assessed in a wide range of data sets on different clinical conditions, before it can be used routinely in health technology assessment.

Indexed as

Quality of LifeAntirheumatic AgentsHumansModels, StatisticalMultivariate AnalysisOutcome Assessment, Health CareRandomized Controlled Trials as TopicSpondylitis, AnkylosingTechnology Assessment, BiomedicalTumor Necrosis Factor-alphaAntirheumatic AgentsTumor Necrosis Factor-alphacongeneric testscross-walkingmappingmultioutcome synthesis

Identifiers

PMID24636388
PMCPMC3991420
OpenAlexW2096322845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.